Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Coagulation | 8 | 2022 | 120 | 1.790 |
Why?
|
| Disseminated Intravascular Coagulation | 3 | 2022 | 16 | 1.470 |
Why?
|
| Peptidoglycan | 6 | 2021 | 47 | 1.270 |
Why?
|
| Anthrax | 3 | 2021 | 91 | 1.150 |
Why?
|
| Monocytes | 3 | 2019 | 135 | 1.120 |
Why?
|
| Bacillus anthracis | 6 | 2021 | 153 | 1.040 |
Why?
|
| Sepsis | 7 | 2021 | 86 | 0.810 |
Why?
|
| Thrombosis | 2 | 2022 | 150 | 0.760 |
Why?
|
| Protein Disulfide-Isomerases | 2 | 2010 | 6 | 0.650 |
Why?
|
| Cytokines | 3 | 2019 | 451 | 0.560 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 169 | 0.560 |
Why?
|
| Phosphatidylserines | 3 | 2013 | 20 | 0.430 |
Why?
|
| Signal Transduction | 2 | 2019 | 1469 | 0.400 |
Why?
|
| Thromboplastin | 4 | 2019 | 28 | 0.400 |
Why?
|
| Papio | 7 | 2021 | 81 | 0.340 |
Why?
|
| Endothelial Cells | 2 | 2011 | 373 | 0.320 |
Why?
|
| Factor VIIa | 1 | 2010 | 29 | 0.320 |
Why?
|
| Escherichia coli | 4 | 2020 | 338 | 0.270 |
Why?
|
| Bacteremia | 2 | 2019 | 81 | 0.260 |
Why?
|
| Flow Cytometry | 3 | 2019 | 292 | 0.240 |
Why?
|
| Immunity, Innate | 2 | 2018 | 231 | 0.240 |
Why?
|
| Cell Wall | 2 | 2021 | 67 | 0.200 |
Why?
|
| Peptides, Cyclic | 2 | 2015 | 30 | 0.200 |
Why?
|
| Escherichia coli Infections | 2 | 2015 | 45 | 0.200 |
Why?
|
| Fibrinolysis | 1 | 2022 | 21 | 0.190 |
Why?
|
| Hemostasis | 1 | 2022 | 48 | 0.180 |
Why?
|
| Complement C5 | 1 | 2021 | 4 | 0.180 |
Why?
|
| Anemia, Hemolytic | 1 | 2021 | 22 | 0.180 |
Why?
|
| Lung | 3 | 2015 | 382 | 0.170 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 74 | 0.170 |
Why?
|
| Animals | 11 | 2021 | 10684 | 0.170 |
Why?
|
| Humans | 13 | 2022 | 28851 | 0.170 |
Why?
|
| Brefeldin A | 1 | 2019 | 5 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 82 | 0.150 |
Why?
|
| Lipoproteins | 2 | 2011 | 99 | 0.150 |
Why?
|
| Immunoglobulin G | 2 | 2018 | 272 | 0.150 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 92 | 0.150 |
Why?
|
| Prekallikrein | 1 | 2018 | 2 | 0.140 |
Why?
|
| Factor XIIa | 1 | 2018 | 3 | 0.140 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 157 | 0.140 |
Why?
|
| Serum Amyloid P-Component | 1 | 2018 | 9 | 0.140 |
Why?
|
| Papio anubis | 1 | 2018 | 48 | 0.140 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2018 | 34 | 0.140 |
Why?
|
| Complement Activation | 2 | 2015 | 27 | 0.140 |
Why?
|
| Biomarkers | 2 | 2019 | 776 | 0.140 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 121 | 0.130 |
Why?
|
| Inflammation | 3 | 2020 | 667 | 0.130 |
Why?
|
| Hexokinase | 1 | 2016 | 16 | 0.130 |
Why?
|
| Inflammasomes | 1 | 2016 | 20 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 2016 | 73 | 0.120 |
Why?
|
| Complement Inactivating Agents | 1 | 2015 | 3 | 0.120 |
Why?
|
| Alpha-Globulins | 1 | 2015 | 8 | 0.110 |
Why?
|
| Glycosaminoglycans | 1 | 2015 | 55 | 0.110 |
Why?
|
| Histones | 1 | 2015 | 96 | 0.110 |
Why?
|
| Acute Lung Injury | 1 | 2014 | 12 | 0.110 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 113 | 0.100 |
Why?
|
| Complement System Proteins | 1 | 2013 | 24 | 0.100 |
Why?
|
| Receptors, IgG | 1 | 2013 | 47 | 0.100 |
Why?
|
| Platelet Activation | 1 | 2013 | 54 | 0.100 |
Why?
|
| Hemorrhage | 1 | 2015 | 266 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 634 | 0.090 |
Why?
|
| Protein Binding | 2 | 2013 | 667 | 0.090 |
Why?
|
| Androgens | 1 | 2011 | 47 | 0.090 |
Why?
|
| Apoptosis | 2 | 2015 | 780 | 0.080 |
Why?
|
| Male | 4 | 2021 | 13921 | 0.080 |
Why?
|
| Complement Inactivator Proteins | 1 | 2010 | 8 | 0.080 |
Why?
|
| Luminescent Proteins | 1 | 2010 | 26 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 42 | 0.080 |
Why?
|
| Extracellular Space | 1 | 2010 | 26 | 0.080 |
Why?
|
| Allosteric Site | 1 | 2010 | 11 | 0.080 |
Why?
|
| Multiple Organ Failure | 1 | 2010 | 31 | 0.080 |
Why?
|
| Oxidants | 1 | 2010 | 31 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 50 | 0.080 |
Why?
|
| Oxidoreductases | 1 | 2010 | 57 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2010 | 267 | 0.080 |
Why?
|
| Anticoagulants | 2 | 2011 | 297 | 0.080 |
Why?
|
| Female | 4 | 2021 | 15624 | 0.080 |
Why?
|
| Calcium | 1 | 2010 | 243 | 0.070 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 380 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2010 | 268 | 0.070 |
Why?
|
| Lipids | 1 | 2010 | 218 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2011 | 485 | 0.070 |
Why?
|
| Papio cynocephalus | 1 | 2007 | 5 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 472 | 0.070 |
Why?
|
| Peptides | 1 | 2010 | 296 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2010 | 302 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2010 | 497 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 482 | 0.060 |
Why?
|
| Fibrosis | 2 | 2015 | 142 | 0.050 |
Why?
|
| Mice | 3 | 2018 | 4802 | 0.050 |
Why?
|
| Hemolysis | 1 | 2021 | 51 | 0.040 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2020 | 14 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 1653 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 58 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 1507 | 0.030 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 16 | 0.030 |
Why?
|
| Potassium | 1 | 2016 | 43 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 41 | 0.030 |
Why?
|
| Acetylglucosamine | 1 | 2016 | 17 | 0.030 |
Why?
|
| Glycolysis | 1 | 2016 | 96 | 0.030 |
Why?
|
| Glycocalyx | 1 | 2015 | 4 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2015 | 22 | 0.030 |
Why?
|
| Nucleosomes | 1 | 2015 | 18 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 2015 | 44 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2016 | 143 | 0.030 |
Why?
|
| Models, Biological | 1 | 2016 | 469 | 0.030 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2013 | 15 | 0.030 |
Why?
|
| Plasma | 1 | 2013 | 32 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 79 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 515 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 156 | 0.020 |
Why?
|
| Mitochondria | 1 | 2016 | 408 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 1022 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2011 | 39 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2013 | 206 | 0.020 |
Why?
|
| Caveolin 1 | 1 | 2011 | 43 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 34 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 202 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 190 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 328 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2010 | 357 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2007 | 20 | 0.020 |
Why?
|
| Fibrinolysin | 1 | 2007 | 16 | 0.020 |
Why?
|
| Antibodies | 1 | 2007 | 125 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 1350 | 0.020 |
Why?
|
| Neutrophils | 1 | 2007 | 183 | 0.020 |
Why?
|
| Macrophages | 1 | 2007 | 305 | 0.010 |
Why?
|